AWARDS

AWARDS | CORPORATE | EVENTS

Odimma Therapeutics Recognized Among Europe’s Most Innovative Biotech Companies at BioFIT 2022
November 30, 2022June 10, 2026

——————— Awarded the Merck Group Special Prize for Innovation in Personalized Oncology. Odimma Therapeutics was honored at BioFIT 2022, Europe’s leading partnering event dedicated to technology transfer, biotechnology innovation and academia-industry collaborations, by receiving the Merck Group Special Prize Awardduring the prestigious Start-up Slams competition. The distinction recognized Odimma as one of Europe’s most promising biotechnology innovators, highlighting…

Read More Odimma Therapeutics Recognized Among Europe’s Most Innovative Biotech Companies at BioFIT 2022
AWARDS | CORPORATE

Odimma Therapeutics Selected as a Finalist for WiClub Health #2
November 1, 2022June 9, 2026

——————— Recognition Supporting the Company’s Clinical Development Ambitions. Odimma Therapeutics was selected as one of the five innovative biotechnology companies chosen to participate in the second edition of WiClub Health, a funding initiative supported by WiSEED, France’s leading equity crowdfunding platform, in partnership with SEMIA and Quest for Health. The selection recognized the maturity of Odimma’s personalized cancer immunotherapy platform and its…

Read More Odimma Therapeutics Selected as a Finalist for WiClub Health #2
AWARDS | CORPORATE | EVENTS

Odimma Therapeutics Named Among France’s “100 Start-ups to Invest in 2021”
March 25, 2021June 9, 2026

——————— National Recognition for Innovation in Personalized Oncology. Odimma Therapeutics was selected as one of France’s “100 Start-ups to Invest in 2021”, a prestigious ranking published by Challenges, one of the country’s leading business and economic magazines. The recognition highlighted Odimma’s innovative approach to personalized cancer immunotherapy and its ambition to transform precision oncology through next-generation immune-based therapies tailored…

Read More Odimma Therapeutics Named Among France’s “100 Start-ups to Invest in 2021”